SomaLogic, Inc.
SLGC · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $22 | $20 | $20 | $19 |
| % Growth | 7.7% | 0.4% | 8.2% | – |
| Cost of Goods Sold | $12 | $11 | $12 | $13 |
| Gross Profit | $10 | $9 | $8 | $6 |
| % Margin | 47.2% | 45.4% | 39.6% | 31.1% |
| R&D Expenses | $10 | $11 | $14 | $23 |
| G&A Expenses | $0 | $0 | $0 | $34 |
| SG&A Expenses | $24 | $30 | $34 | $38 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $4 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $34 | $40 | $48 | $60 |
| Operating Income | -$28 | -$31 | -$40 | -$54 |
| % Margin | -127.4% | -151.9% | -197.2% | -289.3% |
| Other Income/Exp. Net | $6 | $6 | $6 | $5 |
| Pre-Tax Income | -$22 | -$25 | -$34 | -$49 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$22 | -$25 | -$34 | -$49 |
| % Margin | -100.5% | -121% | -167.8% | -261.6% |
| EPS | -0.12 | -0.13 | -0.18 | -0.26 |
| % Growth | 7.7% | 27.8% | 30.8% | – |
| EPS Diluted | -0.12 | -0.13 | -0.18 | -0.26 |
| Weighted Avg Shares Out | 187 | 187 | 187 | 186 |
| Weighted Avg Shares Out Dil | 187 | 187 | 187 | 186 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $6 | $5 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | -$1 | $5 |
| EBITDA | -$18 | -$30 | -$40 | -$50 |
| % Margin | -82.5% | -145.3% | -197.2% | -265% |